Novel recombinant human thyroid-stimulating hormone in aiding postoperative assessment of patients with differentiated thyroid cancer-phase I/II study.
Yan-Song LinHui YangXiao-Yi LiLi-Qing WuJin-Guo XuAi-Min YangZai-Rong GaoYong DingYing-Qiang ZhangKai ChenZhuan-Zhuan MuJian-Min JiaNa NiuDi SunXin ZhangShao-Qiang ZhangQian-Qian GengYa-Jing ZhangFang-Ni ChenBao-Xia HePublished in: European journal of nuclear medicine and molecular imaging (2022)
The ZGrhTSH held the promise to be a safe and effective modality in facilitating RAI uptake and serum thyroglobulin stimulation, with better QoL of patients with DTC compared with L-T<sub>4</sub> withdrawal.